{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:24:45Z","timestamp":1768353885082,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pathol.2020.09.030","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T20:17:28Z","timestamp":1611865048000},"page":"639-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antifungal susceptibility of clinical mould isolates in New Zealand, 2001\u20132019"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-7187","authenticated-orcid":false,"given":"Arthur J.","family":"Morris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy P.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-1017","authenticated-orcid":false,"given":"Karen","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2020.09.030_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.pathol.2020.09.030_bib2","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01618-06","article-title":"Universal in\u00a0vitro antifungal resistance of genetic clades of the Fusarium solani species complex","volume":"51","author":"Azor","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib3","series-title":"Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing","year":"2016"},{"key":"10.1016\/j.pathol.2020.09.030_bib4","series-title":"Epidemiological cutoff values for antifungal susceptibility testing","year":"2018"},{"key":"10.1016\/j.pathol.2020.09.030_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.pathol.2020.09.030_bib6","series-title":"Descriptions of Medical Fungi","year":"2016"},{"key":"10.1016\/j.pathol.2020.09.030_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijantimicag.2016.07.005","article-title":"Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations","volume":"48","author":"Halliday","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pathol.2020.09.030_bib8","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/jac\/dky187","article-title":"Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates","volume":"73","author":"Talbot","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib9","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard","year":"2008"},{"key":"10.1016\/j.pathol.2020.09.030_bib10","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","year":"2017"},{"key":"10.1016\/j.pathol.2020.09.030_bib11","series-title":"Performance standards for the antifungal susceptibility testing of filamentous fungi","year":"2020"},{"key":"10.1016\/j.pathol.2020.09.030_bib12","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 Document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pathol.2020.09.030_bib13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distributions for epidemiological cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.02456-15","article-title":"International evaluation of MIC distributions and epidemiological cuff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method","volume":"60","author":"Espinel-Ingroff","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib15","series-title":"Species-specific, in-vitro, antifungal susceptibility patterns and epidemiological cut-off values for Scedosporium","author":"Lackner","year":"2012"},{"key":"10.1016\/j.pathol.2020.09.030_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01651-18","article-title":"Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre YeastOne colorimetric broth and Etest agar diffusion methods","volume":"63","author":"Espinel-ingroff","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1439-0507.2002.00797.x","article-title":"Aspergillus nidulans is frequently resistant to amphothericin B","volume":"45","author":"Kontoyiannis","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.pathol.2020.09.030_bib18","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.37.7.2343-2345.1999","article-title":"In\u00a0vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole","volume":"37","author":"Sutton","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pathol.2020.09.030_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international study of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.pathol.2020.09.030_bib20","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.pathol.2020.09.030_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.pathol.2020.09.030_bib22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/imj.12598","article-title":"Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014","volume":"44","author":"Blyth","year":"2014","journal-title":"Int Med J"},{"key":"10.1016\/j.pathol.2020.09.030_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2217\/fmb-2018-0059","article-title":"Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside","volume":"13","author":"Beardsley","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.pathol.2020.09.030_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archopht.125.6.789","article-title":"Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis","volume":"23","author":"Lalitha","year":"2007","journal-title":"Arch Opthalmol"},{"key":"10.1016\/j.pathol.2020.09.030_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dkn022","article-title":"Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods","volume":"61","author":"Alastruey-Izquierdo","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib26","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/AAC.00272-08","article-title":"Species distribution and in\u00a0vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from Northern Italy","volume":"52","author":"Tortorano","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib27","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific susceptibility patterns of Scedosporium and Pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib28","first-page":"1050","article-title":"In\u00a0vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi","volume":"56","author":"Biswas","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.pathol.2020.09.030_bib29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.01539-06","article-title":"In\u00a0vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of Zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest","volume":"51","author":"Torres-Narbona","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib30","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/AAC.05959-11","article-title":"Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis","volume":"56","author":"Meletiadis","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pathol.2018.01.001","article-title":"Antifungal susceptibility testing in Australasian clinical laboratories: we must improve our performance","volume":"50","author":"Kidd","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2020.09.030_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkz534","article-title":"Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013","volume":"75","author":"Parent-Michaud","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pathol.2020.09.030_bib33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/CMR.00095-16","article-title":"Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species","volume":"30","author":"Dudakova","year":"2017","journal-title":"Clin Microbiol Rev"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:27:30Z","timestamp":1758472050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0031302521000027"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.09.030","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal susceptibility of clinical mould isolates in New Zealand, 2001\u20132019","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}